This review provides evidence for the vulnerability of foetal gonads to cancer therapy agents and the potentially damaging effects of in utero exposure on gonadal development and reproductive health. We hope these findings help raise awareness for the need of long-term follow-up studies to explore whether fertility is impacted in people who were exposed to cancer agents in utero and to identify whether they may require fertility preservation strategies.